Posts

Showing posts with the label Immunotherapy

The New Dawn in Bladder Cancer: EV-302 and the End of the "Chemo-Only" Era

2025 updates to TOPAZ-1

EV-302: The Trial That Revolutionized First-Line Bladder Cancer Treatment

Practice Changing Article review : CheckMate 649 - Five-Year Survival Data Redefines the Standard of Care for Advanced Gastric Cancer

Top 10 things in Immuno-oncology to take away from 2025

Clinical Guide for Management of MMM (Myositis-Myocarditis-Myasthenia Gravis) Overlap Syndrome Evidence-Based Guide for Healthcare Professionals

Article review: Long term results of Keynote 412- supports lack of clear benefit by immunotherapy to CRT in H&N cancers

High Impact Article review : Durvalumab in MIBC , NIAGARA study

Immunotherapy Toxicity : Summary guide for ready reference

Weekly Journal Scan : Focus on Immunotherapy this week

Contact Form

Name

Email *

Message *